BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28206965)

  • 1. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhao Y; Si G; Zhu F; Hui J; Cai S; Huang C; Cheng S; Fathy AH; Xiang Y; Li J
    Oncotarget; 2017 Apr; 8(14):22854-22862. PubMed ID: 28206965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
    Ma W; Zhang P; Qi J; Gu L; Zang M; Yao H; Shi X; Wang C; Jiang Y
    Sci Rep; 2016 Oct; 6():35378. PubMed ID: 27739490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
    Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.
    Yang HJ; Jiang JH; Liu QA; Zhou CM; Du YF; Wu T; Chen NZ; Xiang BD
    Tumour Biol; 2017 Jun; 39(6):1010428317707375. PubMed ID: 28639906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma.
    Song W; Wang K; Zhong FP; Fan YW; Peng L; Zou SB
    Oncotarget; 2016 Dec; 7(49):81830-81838. PubMed ID: 27833084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.
    Li X; Chen ZH; Xing YF; Wang TT; Wu DH; Wen JY; Chen J; Lin Q; Dong M; Wei L; Ruan DY; Lin ZX; Wu XY; Ma XK
    Tumour Biol; 2015 Apr; 36(4):2263-9. PubMed ID: 25409616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between platelet to lymphocyte ratio (PLR) and overall survival (OS) of hepatocellular carcinoma (HCC): A meta-analysis.
    Hu DH; Yu SM
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):30-32. PubMed ID: 28886327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Pre-Operative Platelet to Lymphocyte Ratio in Patients with Resected Primary Hepatocellular Carcinoma.
    Dong L; Bai K; Cao Y; Huang Q; Lv L; Jiang Y
    Clin Lab; 2016 Nov; 62(11):2191-2196. PubMed ID: 28164677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
    Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of preoperative platelet-to-lymphocyte ratio in recurrent hepatocellular carcinoma after thermal ablation: A retrospective analysis.
    Li X; Han Z; Cheng Z; Yu J; Yu X; Liang P
    Int J Hyperthermia; 2015; 31(7):758-63. PubMed ID: 26391553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio.
    Xia W; Ke Q; Guo H; Wang W; Zhang M; Shen Y; Wu J; Xu X; Yan S; Yu J; Zhang M; Zheng S
    BMC Cancer; 2017 Jan; 17(1):14. PubMed ID: 28056901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: A systematic review and meta-analysis.
    Lai Q; Melandro F; Larghi Laureiro Z; Giovanardi F; Ginanni Corradini S; Ferri F; Hassan R; Rossi M; Mennini G
    World J Gastroenterol; 2018 Apr; 24(15):1658-1665. PubMed ID: 29686473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
    Li DZ; Guo J; Song QK; Hu XJ; Bao XL; Lu J
    Transl Cancer Res; 2022 Nov; 11(11):4037-4050. PubMed ID: 36523315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
    Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
    Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation.
    Xia W; Ke Q; Wang Y; Wang W; Zhang M; Shen Y; Wu J; Xu X; Zheng S
    World J Surg Oncol; 2015 Feb; 13():60. PubMed ID: 25885777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis.
    Wang Y; Peng C; Cheng Z; Wang X; Wu L; Li J; Huang C; Guo Q; Cai H
    Int J Surg; 2018 Jul; 55():73-80. PubMed ID: 29787804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis.
    Lin WF; Zhong MF; Zhang YR; Wang H; Zhao HT; Cheng BB; Ling CQ
    Gastroenterol Res Pract; 2018; 2018():5670949. PubMed ID: 30158964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients.
    Gu X; Sun S; Gao XS; Xiong W; Qin S; Qi X; Ma M; Li X; Zhou D; Wang W; Yu H
    Sci Rep; 2016 Mar; 6():23893. PubMed ID: 27025911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.